Systematic review and meta-analysis of Sniffin Sticks Test performance in Parkinson's disease patients in different countries
- PMID: 34319482
- DOI: 10.1007/s00405-021-06970-8
Systematic review and meta-analysis of Sniffin Sticks Test performance in Parkinson's disease patients in different countries
Abstract
Introduction: Olfaction impairment occurs in about 90% of patients with Parkinson's disease. The Sniffin Sticks Test is a widely used instrument to measure olfactory performance and is divided into three subtests that assess olfactory threshold, discrimination and identification. However, cultural and socioeconomic differences can influence test performance.
Objectives: We performed a systematic review and meta-analysis of the existent data about Sniffin Sticks Test performance of Parkinson's disease patients and healthy controls in different countries and investigated if there are other cofactors which could influence the olfactory test results. A subgroup analysis by country was performed as well as a meta-regression using age, gender and air pollution as covariates.
Results: Four hundred and thirty studies were found and 66 articles were included in the meta-analysis. Parkinson's disease patients showed significantly lower scores on the Sniffin Sticks Test and all its subtests than healthy controls. Overall, the heterogeneity among studies was moderate to high as well as the intra-country heterogeneity. The subgroup analysis, stratifying by country, maintained a high residual heterogeneity.
Conclusion: The meta-regression showed a significant correlation with age and air pollution in a few subtests. A high heterogeneity was found among studies which was not significantly decreased after subgroup analysis by country. This fact signalizes that maybe cultural influence has a small impact on the Sniffin Sticks Test results. Age and air pollution have influence in a few olfactory subtests.
Keywords: Hyposmia; Olfaction; Parkinson’s disease; Sniffin Sticks Test.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Psychological and/or educational interventions for the prevention of depression in children and adolescents.Cochrane Database Syst Rev. 2004;(1):CD003380. doi: 10.1002/14651858.CD003380.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380. doi: 10.1002/14651858.CD003380.pub3. PMID: 14974014 Updated.
Cited by
-
Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson's disease.J Neurol. 2024 Mar;271(3):1397-1407. doi: 10.1007/s00415-023-12080-8. Epub 2023 Nov 9. J Neurol. 2024. PMID: 37940708
-
Olfactory Dysfunction and Glaucoma.Biomedicines. 2024 May 2;12(5):1002. doi: 10.3390/biomedicines12051002. Biomedicines. 2024. PMID: 38790964 Free PMC article. Review.
-
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease.J Neurol. 2024 Apr;271(4):1959-1972. doi: 10.1007/s00415-023-12122-1. Epub 2023 Dec 27. J Neurol. 2024. PMID: 38151574
-
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson's Disease.J Parkinsons Dis. 2024;14(s2):S275-S285. doi: 10.3233/JPD-230348. J Parkinsons Dis. 2024. PMID: 38517805 Free PMC article. Review.
-
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.Front Neurosci. 2025 Jan 7;18:1505029. doi: 10.3389/fnins.2024.1505029. eCollection 2024. Front Neurosci. 2025. PMID: 39840019 Free PMC article. Review.
References
-
- Tanner CM, Goldman SM (1996) Epidemiology of Parkinson’s Disease. Neuroepidemiology 14(2):317–335
-
- Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH (2010) A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. QJM. 103(12):941–952. https://doi.org/10.1093/qjmed/hcq142 - PubMed
-
- Nielsen T, Jensen MB, Stenager E, Andersen AD (2018) The use of olfactory testing when diagnosing Parkinson’s disease—a systematic review. Dan Med J 65(5):5481
-
- Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601
-
- Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94:176–178 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical